Trevigen launches High-Throughput PARP/Apoptosis Assays ideal for measuring the activity of PARP in 96-well plates. Cell extracts can be obtained using their newly-developed, higher-throughput procedure before, during and after apoptosis induction. During apoptosis, PARP-1 which catalyzes the NAD dependent... - February 20, 2008 - Trevigen, Inc

AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength choices... - February 16, 2008 - AnaSpec, Inc.

Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100 µg Host:... - February 13, 2008 - AnaSpec, Inc.

AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a collection... - February 11, 2008 - AnaSpec, Inc.

Vascular BioSciences announced today it has received a STTR Phase 1 grant from the National Heart Lung Blood Institute of the National Institutes of Health in the amount of $165,745. The STTR award, “Targeting Pulmonary Hypertension with R-Ras,” will be performed in collaboration with principal... - February 10, 2008 - Vascular BioSciences, Inc

Baxa announces the launch of its new corporate Web site with enhanced user features and technical content. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. - January 31, 2008 - Baxa Corporation - Featured Press Release

Representatives from the Colorado BioScience Association (CBSA) and six of the state’s economic development entities are marketing Colorado as a desirable medical device manufacturing hub at the 24th annual Medical Device & Manufacturing (MD&M) West Expo. - January 31, 2008 - Colorado BioScience Association - Featured Press Release

Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat# 54319,... - January 27, 2008 - AnaSpec, Inc.

The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC

Bio-Synthesis Inc., a closely held biotechnology company, is pleased to announce an exclusive scientific collaboration with Dr. Dante Marciani, a world renowned expert in immune agonists. Over the last 20 years, Dr. Marciani has pioneered work with proprietary immune stimulatory saponins and their semi-synthetic... - January 25, 2008 - Bio-Synthesis Inc. - Premium Press Release

New Baxa eCampaign targets IV Nurses to introduce the PadLock Set Saver and honors nurses for their dedication to patients. The PadLock Set Saver device is designed to promote best practice for aseptic IV administration set storage, preventing contamination of the administration set when disconnected from the patient. The Set Saver also eliminates the use of IV administration set caps, which are a known choking hazard – especially in pediatric applications. - January 25, 2008 - Baxa Corporation - Featured Press Release

Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.

AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, Inc.

ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.

Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits. - January 16, 2008 - Anavex Life Sciences Corp.

Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.

Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA (257-264);... - January 04, 2008 - AnaSpec, Inc.

Unparalleled drug-free gains in strength, stamina and mental performance attainable through natural energetic alternative to steroids and banned performance enhancing drugs providing powerful ergogenic effects rivaling steroids, blood doping and other dangerous performance enhancement techniques while enhancing deep delta sleep, cardiovascular efficiency, cellular repair and mental acuity. - January 01, 2008 - EarthPulse Technologies, LLC

The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation - Featured Press Release

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine at... - December 20, 2007 - AnaSpec, Inc.

AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, Inc.

AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, Inc.

Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2 (paired69/71)... - December 15, 2007 - AnaSpec, Inc.

Pulsed magnetic fields provide strong anti-aging effects while enhancing physical performance in older pets where trauma, arthritis or age related joint deformity has resulted in chronic pain, loss of mobility and subsequent changes in behavior. - December 14, 2007 - EarthPulse Technologies, LLC

With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented HiLyte™... - December 14, 2007 - AnaSpec, Inc.

ValveXchange has won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 conference in Denver. The announcement is made by Chris Shapard, Deputy Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards luncheon at the Grand Hyatt Friday. - December 09, 2007 - Colorado BioScience Association - Featured Press Release

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, Inc.

Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced the sale of a fully digital multi-modality molecular imaging system for installation at Louisiana State University Health Sciences Center... - December 07, 2007 - Gamma Medica-Ideas

Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) - Cat#... - December 06, 2007 - AnaSpec, Inc.

AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, Inc.

Baxa announces the introduction of MedBoard, the first wireless medication tracking system. MedBoard is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. With its dynamic order monitoring, MedBoard reduces waste by identifying time-sensitive orders and ensuring on-time delivery. - December 03, 2007 - Baxa Corporation - Featured Press Release

Baxa announces the introduction of its next-generation Repeater Pump, the first no-calibration pharmacy pump, featuring unique P2 technology. The Repeater Pump II is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. - December 03, 2007 - Baxa Corporation - Featured Press Release

The Colorado BioScience Association (CBSA) has released winners of its 2007 Awards Program. Official presentation of the awards occurs Friday, December 7, 11:45 a.m. to 1:15 p.m., at the CBSA’s annual awards luncheon. Held in conjunction with the 2007 BioWest Conference at the Grand Hyatt Denver, registration information is available at the BioWest Conference website. - November 29, 2007 - Colorado BioScience Association - Featured Press Release

AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, Inc.

AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, Inc.

Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss key financial analyses and metrics and how to use them to build a compelling business plan. - November 27, 2007 - Baxa Corporation - Featured Press Release

Colorado-based pharmacy products manufacturer, Baxa Corporation, is sponsoring a program at the annual American Society of Health-System Pharmacists’ Midyear Clinical Meeting in Las Vegas, December 3rd. The speaker will discuss parenteral nutrition safety issues and the differences between standardized formulations and a standardized process. - November 26, 2007 - Baxa Corporation - Featured Press Release

Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced its collaboration with Mayo Clinic in an important, new breast cancer research project. The main goal of the project, funded by a $1.8... - November 23, 2007 - Gamma Medica-Ideas

Company Executives Offer “Crystal Ball” Predictions. VP of Research Discusses Need for New Approaches in Anti-Infectives. - November 22, 2007 - NovaBay Pharmaceuticals, Inc.

Baxa Corporation announces its agreement with MedKeeper to market and sell a Web-based program that tracks pharmacy doses from order entry to delivery. Under the agreement, Baxa Corporation has exclusive sales and distribution rights for all worldwide healthcare markets for the MedKeeper software. - November 21, 2007 - Baxa Corporation - Featured Press Release

IRG to Communicate the Company’s Clinical Development Programs - November 21, 2007 - NovaBay Pharmaceuticals, Inc.

Karen Bernstein, Ph.D., Co-Founder, Chairman & Editor-in-Chief of the BioCentury family of publications, including the well-read “The Bernstein Report on Biobusiness” has been added to the roster of national speakers for BioWest 2007 on Thursday, December 6 (12:15 – 1 p.m.) at the Grand Hyatt Denver. Dr. Bernstein replaces Colorado Governor Bill Ritter for the Thursday luncheon address. The Governor's commitments required his speech be rescheduled to the 2:30 – 3 p.m. time slot the same day. - November 19, 2007 - Colorado BioScience Association - Featured Press Release

AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, Inc.

Glycosan BioSystems launched its new product for cell-based assays Extracel Sponge-96. - November 15, 2007 - Glycosan BioSystems, Inc.

Baxa Corporation announces plans to launch new course offering with an industry forum on USP 797 compliance and facility design. The forum, held in the STAR (Skills Training, Academics and Resources) Center, will bring together industry leaders to better understand the requirements of USP 797 and their practical application for facility design and environmental control. - November 14, 2007 - Baxa Corporation - Featured Press Release

According to SynRG Orange Paper, in the 3rd Quarter 2007, the overall volume of the clinical trials in Russia and its basic parameters are generally the same as in the corresponding quarter of the last year. In the 3rd Quarter 2007 RosZdravNadzor (RZN) has issued 141 approvals for conducting new clinical trials, which is 2% more than in Q3 2006. - November 14, 2007 - Synergy Research Group

CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2007 Mature Company Forum on December 6th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Mature Company Forum include Bob Conway, Array Biopharma; Greg Baldwin, Baxa Corporation; Jeff Probst, Blue Sun Biodiesel; Chris Smith, Cochlear Americas; and Bob Grieve, Heska Corporation. - November 12, 2007 - Colorado BioScience Association - Featured Press Release

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death and... - November 11, 2007 - AnaSpec, Inc.

Bio-Synthesis is expanding Dye Labeling Licensing - November 09, 2007 - Bio-Synthesis Inc. - Premium Press Release